Expression of Serotonin1A and Serotonin2A Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex
The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Serotonergic 5-HT1A and 5-HT2A receptors are abundantly expressed in prefrontal cortex (PFC) and are targets of atypical antipsychotic drugs. They mediate, respectively, inhibitory and excitatory actions of 5-HT. The transcripts for both receptors are largely (approximately 80%) colocalized in rat and mouse PFC, yet their quantitative distribution in pyramidal and GABAergic interneurons is unknown. We used double in situ hybridization histochemistry to estimate the proportion of pyramidal and GABAergic neurons expressing these receptor transcripts in rat PFC. The number of GABAergic interneurons (expressing GAD mRNA) was a 22% of glutamatergic neurons (expressing vGluT1 mRNA, considered as putative pyramidal neurons). 5-HT2A receptor mRNA was present in a large percentage of pyramidal neurons (from 55% in prelimbic cortex to 88% in tenia tecta), except in layer VI, where it was localized only in 30% of those neurons. 5-HT2A receptor mRNA was present in approximately 25% of GAD-containing cells except in layer VI (10%). Likewise, approximately 60% of glutamatergic cells contained the 5-HT1A receptor transcript. We also found that approximately 25% of GAD-expressing cells contained the 5-HT1A receptor mRNA. These data help to clarify the role of 5-HT in prefrontal circuits and shed new light to the cellular elements involved in the action of atypical antipsychotics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rodents, this expression pattern has been confirmed using immunohistochemistry (203–206), light and electron microscope immunocytochemistry (203), in situ hybridization (207, 208), receptor autoradiography (209), and transgenic mice expressing EGFP under control of the 5-HT2A receptor promoter (210).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [208]
In the citing paper
“These receptors mediate, respectively, the inhibitory and excitatory actions of 5-HT on cortical neurons (108); thus these alterations may produce further functional abnormalities in the anterior cingulate cortex.”
From Functional disturbances within frontostriatal circuits across multiple childhood psychopathologies (2009) · cites this paper as [108]
In the citing paper
“amplifies 5-HT1A-R-mediated inhibition of GABAergic interneurons (Santana et al., 2004) to disinhibit glutamatergic output in downstream structures (Llado-Pelfort et al., 2012).”
From The endocannabinoid system as a target for novel anxiolytic drugs (2017) · cites this paper as Santana et al., 2004
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963 · cited 1×
“Cortical areas designated according to Paxinos and Watson (1998) and Swanson (1998).”
Azmitia, E. C., & Segal, M. (1978) · Journal of Comparative Neurology · doi:10.1002/cne.901790311 · Cited by 1,909 · cited 2×
“The prefrontal cortex receives a moderate to dense serotonergic innervation from the raphe nuclei (Azmitia and Segal, 1978; Steinbusch, 1981; Blue et al., 1988) and contains several serotonin (5-hydroxytryptamine, 5-HT) receptor subtypes, with a particularly high density of 5-HT1A and 5-HT2A receptors (Pazos and Palac…”
BackgroundBrain Maps: Structure of the Rat Brain
Swanson, L. W. (1992) · Medical Entomology and Zoology · Cited by 1,878
Pazos, A., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855 · cited 2×
“…the raphe nuclei (Azmitia and Segal, 1978; Steinbusch, 1981; Blue et al., 1988) and contains several serotonin (5-hydroxytryptamine, 5-HT) receptor subtypes, with a particularly high density of 5-HT1A and 5-HT2A receptors (Pazos and Palacios, 1985; Pazos et al., 1985; Pompeiano et al., 1992, 1994).”
BackgroundSesack, S. R., Deutch, A. Y., Roth, R. H., & Bunney, B. S. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902900205 · Cited by 1,568 · cited 2×
“Of particular interest are the many neurons of the prelimbic and infralimbic areas expressing 5-HT2A and/or 5-HT1A receptors, since these areas project to midbrain serotonergic and dopaminergic cells and influence their activity (Thierry et al., 1983; Sesack et al., 1989; Hajós et al., 1998; Peyron et al., 1998; Carr…”
BackgroundLaruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291 · cited 1×
“This effect would attenuate the presumed hyperactivity of mesolimbic dopamine neurons in schizophrenic patients (Weinberger et al., 1994; Laruelle et al., 1996).”
BackgroundThe Expression of Vesicular Glutamate Transporters Defines Two Classes of Excitatory Synapse
Fremeau, R. T., Troyer, M. D., Pahner, I., Nygaard, G. O., Tran, C. H., Reimer, R. J., Bellocchio, E. E., Fortin, D., Storm-Mathisen, J., & Edwards, R. H. (2001) · Neuron · doi:10.1016/s0896-6273(01)00344-0 · Cited by 1,265
Two genes encode distinct glutamate decarboxylases
Erlander, M. G., Tillakaratne, N. J. K., Feldblum, S., Patel, N., & Tobin, A. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90077-d · Cited by 1,213 · cited 1×
“Immunohistochemical and in situ hybridization histochemistry indicate that the majority of GABA-containing neurons in the brain co-express the genes encoding the two GAD isoforms (Erlander et al., 1991; Esclapez et al., 1993, 1994; Feldblum et al., 1993).”
BackgroundPompeiano, M., Palacios, J. M., & Mengod, G. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90223-2 · Cited by 881 · cited 3×
“The distribution of cells expressing the receptor transcripts agrees well with the regional patterns of distribution of the respective mRNA and protein, as assessed autoradiographically (Pazos et al., 1985; Pompeiano et al., 1992, 1994).”
BackgroundCarr, D. B., & Sesack, S. R. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03864.2000 · Cited by 880 · cited 3×
“The occupancy of these pyramidal receptors by atypical antipsychotics should conceivably result in a diminished excitatory input onto mesolimbic dopaminergic neurons, innervated by prefrontal afferents (Thierry et al., 1983; Carr and Sesack, 2000).”
Background
Cited by
Items 201–300 of 546
Weikop, P., Kehr, J., & Scheel-Krüger, J. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107077347 · Cited by 37
“…the PFC activity by mediating a balance between the excitatory 5-HT2A receptors and the inhibitory 5-HT1A receptors both located at the PFC pyramidal cells and the local GABA interneurons (Martin-Ruiz et al., 2001; Celada et al., 2001; Puig et al., 2003; Santana et al., 2004; Adell et al., 2005).”
BackgroundFear signaling in the prelimbic-amygdala circuit: a computational modeling and recording study
Pendyam, S., Bravo-Rivera, C., Burgos-Robles, A., Sotres-Bayon, F., Quirk, G. J., & Nair, S. S. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00961.2012 · Cited by 35
“receptors in PL (Santana et al. 2004).”
Satała, G., Duszyńska, B., Stachowicz, K., Rafało-Ulińska, A., Pochwat, B., Luckhart, C., Albert, P. R., Daigle, M., Tanaka, K. F., Hen, R., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9586-3 · Cited by 39
“cleus and the heteroreceptors expressed postsynaptically in the prefrontal cortex (PFC), amygdala and hippocampus [17, 18].”
Hage, C. E., Rappeneau, V., Etiévant, A., Morel, A., Scarna, H., Zimmer, L., & Bérod, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043535 · Cited by 39
“This ratio, which concords with the estimated proportion of these two populations of neurons in various cortical areas [71], was not affected in cocaine withdrawn rats.”
BackgroundWischhof, L., & Koch, M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2441-y · Cited by 38
“5-HT2A receptors are known to be expressed abundantly in cortical pyramidal cells but only in 25% of GABAergic interneurons (Santana et al. 2004), most of them containing either Parv or calbindin (Jakab and Goldman-Rakic 1998; de Almeida and Mengod 2007).”
BackgroundBarroso‐Chinea, P., Aymerich, M. S., Castle, M., Pérez‐Manso, M., Tuñón, T., Erro, E., & Lanciego, J. L. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2006.12.017 · Cited by 38
Meunier, C. N. J., Amar, M., Lanfumey, L., Hamon, M., & Fossier, P. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.003 · Cited by 38
“Since 5-HT1ARs are expressed by 25% of GABAergic neurons (Santana et al., 2004), they could control inhibition.”
BackgroundWang, S., Zhang, Q. J., Liu, J., Wu, Z., Ali, U., Wang, Y., Chen, L., & Gui, Z. H. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.04.069 · Cited by 38
Pytka, K., Głuch‐Lutwin, M., Kotańska, M., Waszkielewicz, A. M., Kij, A., & Walczak, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0605-4 · Cited by 37
“, γ-aminobutyric acid or glutamate) [5, 6].”
Bombardi, C. (2010) · Brain Research · doi:10.1016/j.brainres.2010.11.055 · Cited by 37
Raab, K., Kirsch, P., & Mier, D. U. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.08.031 · Cited by 37
“In the prefrontal cortex the 5-HT2A receptor is expressed in pyramidal neurons and interneurons (Santana et al., 2004; Willins et al., 1997) and is functionally involved in the modulation of GABA and glutamate release (Abi-Saab et al., 1999; Aghajanian and Marek, 1999; De Almeida and Mengod, 2007;…”
BackgroundCelada, P., Lladó-Pelfort, L., Santana, N., Kargieman, L., Troyano‐Rodriguez, E., Riga, M. S., & Artigas, F. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000643 · Cited by 36
“CM/MD, centromedial and dorsomedial nuclei of the thalamus; GABA, Modified from Santana et al. (2011). Thalamocortical networks in schizophrenia 2151”
BackgroundSelf-citationSerotonergic modulation of spatial working memory: predictions from a computational network model
Cano-Colino, M., Almeida, R., & Compte, A. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00071 · Cited by 36
“5-HT1A and 5-HT2A receptors are the two most abundant receptors in the PFC (Santana et al., 2004), which are highly co-localized in pyramidal neurons (∼80”
BackgroundClozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801
Scorza, M. C., Castañé, A., Bortolozzi, A. A., & Artigas, F. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.012 · Cited by 35
“Hence, it seems plausible that affective and cognitive functions may be more dependent on 5-HT1A receptors, which are mostly expressed in cortico-limbic areas including the prefrontal cortex (Pompeiano et al., 1992; Santana et al., 2004).”
Xu, C., Ma, X.-M., Chen, H.-B., Zhou, M.-H., Qiao, H., & An, S.-C. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.020 · Cited by 34
Śniecikowska, J., Newman‐Tancredi, A., & Kołaczkowski, M. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190911122040 · Cited by 34
Miquel-Rio, L., Sarriés-Serrano, U., Pavia-Collado, R., Meana, J. J., & Bortolozzi, A. A. (2023) · Biomedicines · doi:10.3390/biomedicines11020541 · Cited by 34
“The vmPFC, which is composed of 75–80% glutamatergic pyramidal projection neurons and 20–25% GABAergic local circuit interneurons, is strongly innervated by DR 5-HT neurons [53,54].”
BackgroundWerle, I., Nascimento, L. M. M., dos Santos, A. L. A., Soares, L. A., SANTOS, R. G. D., Hallak, J. E. C., & Bertoglio, L. J. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16315 · Cited by 34
Dopamine Neurotransmission and Atypical Antipsychotics in Prefrontal Cortex: A Critical Review
Masana, M., Santana, N., Artigas, F., & Bortolozzi, A. A. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612805289872 · Cited by 34
Self-citationJanać, B., Tovilović-Kovačević, G., Tomić, M., Prolić, Z., & Radenović, L. (2009) · PubMed · Cited by 34
Santana, N., & Artigas, F. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw148 · Cited by 34
“5-HT3-R (Puig et al. 2004)—but not 5-H11A-R or 5-HT2A-R (Santana et al. 2004)—are also present in layer I GABAergic interneurons, indicating the existence of a complex serotonergic control of distal inputs onto apical dendrites.”
BackgroundResultSelf-citationSimmler, L. D., Anacker, A. M. J., Levin, M., Vaswani, N. M., Gresch, P. J., Nackenoff, A. G., Anastasio, N. C., Stutz, S. J., Cunningham, K. A., Wang, J., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13899 · Cited by 34
“Serotonergic inputs innervate and excite GABAergic interneurons in many cortical regions including these three regions (Freund et al., 1990; Gellman and Aghajanian, 1993; Santana et al., 2004).”
BackgroundChemical Neuroanatomy of 5-HT Receptor Subtypes in the Mammalian Brain
Mengod, G., Vilaró, M. T., Cortés, R., López-Giménez, J. F., Raurich, A., & Palacios, J. M. (2006) · The Receptors · doi:10.1007/978-1-59745-080-5_10 · Cited by 33
Dysregulated neuromodulation in the anterior cingulate cortex in chronic pain
Lançon, K., & Séguéla, P. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1289218 · Cited by 34
Komorowski, A., James, G. M., Philippe, C., Gryglewski, G., Bauer, A., Hienert, M., Spies, M., Kautzky, A., Vanicek, T., Hahn, A., et al. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhw355 · Cited by 32
“In contrast, 5-HT2A receptors, located postsynaptically, are mainly excitatory receptors that modulate GABAergic and glutamatergic neurons (Santana et al. 2004; de Almeida and Mengod 2007).”
BackgroundOpposing Cholinergic and Serotonergic Modulation of Layer 6 in Prefrontal Cortex
Sparks, D. W., Tian, M. K., Sargin, D., Venkatesan, S., Intson, K., & Lambe, E. K. (2018) · Frontiers in Neural Circuits · doi:10.3389/fncir.2017.00107 · Cited by 33
“Similarly, there is prominent expression of 5-HT1A receptors (Amargós-Bosch et al., 2004; Santana et al., 2004).”
BackgroundWang, S., Zhang, Q., Liu, J., Ali, U., Wu, Z. H., Chen, L., Gui, Z. H., Wang, Y., & Hui, Y. P. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.05.029 · Cited by 33
“The GABAergic interneurons in mPFC express both 5-HT2A and 5-HT2C receptors and regulate the activity of pyramidal neurons (Willins et al., 1997; Santana et al., 2004; Liu et al., 2007), we assessed the involvement of GABAergic interneurons.”
BackgroundInfluentialSzpręgiel, I., & Bysiek, A. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00660-y · Cited by 32
Fan, L., Zhang, Q. J., Liu, J.-R., Feng, J., Gui, Z. H., Ali, U., Zhang, L., Hou, C., Wang, T., Hui, Y. P., et al. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.011 · Cited by 32
“…(serotonin, 5-HT) innervations from the midbrain raphe nuclei (Steinbusch, 1981; O’Hearn and Molliver, 1984), and expresses several 5-HT receptor subtypes, including 5-HT1A, -HT2, 5-HT3 and 5-HT7 (Gustafson et al., 1996; Morales et al., 1996; Morales and Bloom, 1997; Santana et al., 2004).”
BackgroundInfluentialWang, Y., Zhang, Q., Liu, J., Ali, U., Gui, Z. H., Hui, Y. P., Wang, T., Chen, L., & Li, Q. (2010) · Brain Research · doi:10.1016/j.brainres.2010.02.009 · Cited by 31
“5-HT1A and 5-HT2 receptors are founded in pyramidal neurons in PFC (Santana et al., 2004).”
In vivo biased agonism at 5-HT1A receptors: characterisation by simultaneous PET/MR imaging
Vidal, B., Fieux, S., Redouté, J., Villien, M., Bonnefoi, F., Bars, D. L., Newman‐Tancredi, A., Costes, N., & Zimmer, L. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0145-2 · Cited by 31
Mora, S., Merchán, A., Vilchez, O., Aznar, S., Klein, A. B., Ultved, L., Campa, L., Sunol, C. E., Flores, P., & Moreno, M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.004 · Cited by 31
“The receptor is densely expressed in the prefrontal cortex (PFC) (Santana et al., 2004); particularly in the glutamatergic pyramidal neurons in layer V (De Almeida and Mengod, 2007).”
Amargós‐Bosch, M., Adell, A., & Artigas, F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04532.x · Cited by 31
“5-HT2A receptors are abundantly expressed by pyramidal neurons in mPFC (Santana et al. 2004) and mediate the excitatory actions of 5-HT in vivo (Amargós-Bosch et al. 2004; Puig et al. 2005) and in vitro (Araneda and Andrade 1991; Aghajanian and Marek 1999).”
BackgroundHammo, A., Wisser, S., & Cichon, J. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02068-0 · Cited by 30
“%) cell types 45 .”
Scorza, M. C., Meikle, M. N., López‐Hill, X., Richeri, A., Lorenzo, D., & Artigas, F. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008432 · Cited by 30
“First, Clz displays lower affinity for D2 than for 5-HT2A receptors (Meltzer, 1999) which are expressed by a very large proportion of PFC neurons (Amargós-Bosch et al., 2004 ; Santana et al., 2004).”
BackgroundSerotonergic Suppression of Mouse Prefrontal Circuits Implicated in Task Attention
Tian, M. K., Schmidt, E. F., & Lambe, E. K. (2016) · eNeuro · doi:10.1523/eneuro.0269-16.2016 · Cited by 29
Gasull-Camós, J., Martínez‐Torres, S., Tarrés-Gatius, M., Ozaita, A., Artigas, F., & Castañé, A. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.06.029 · Cited by 29
“Given the expression of 5-HT1A-R in a large proportion of IL neurons (Santana et al., 2004), we examined their putative involvement in mediating antidepressant-like responses evoked by IL DHK microinfusion.”
Tarrés-Gatius, M., Miquel-Rio, L., Campa, L., Artigas, F., & Castañé, A. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01110-y · Cited by 29
Atorvastatin evokes a serotonergic system-dependent antidepressant-like effect in mice
Ludka, F. K., Constantino, L. C., Kuminek, G., Binder, L. B., Zomkowski, A. D. E., Cunha, M. P., Dal-Cim, T. A., Rodrigues, A. L. S., & Tasca, C. I. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.04.005 · Cited by 28
Modulation of anxiety by cortical serotonin 1A receptors
Piszczek, Ł., Piszczek, A., Kuczmanska, J., Audero, E., & Gross, C. T. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00048 · Cited by 28
“Htr1a has been shown to be expressed not only in glutamatergic principal cells in cortex, hippocampus, and amygdala (Aznar et al., 2003; Santana et al., 2004; Palchaudhuri and Flügge, 2005; De Almeida and Mengod, 2008; Marvin et al., 2010), but also in GABAergic interneurons in these structures…”
BackgroundMolecular and Medical Aspects of Psychedelics
Wojtas, A., & Gołembiowska, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010241 · Cited by 27
“80% [124–126].”
BackgroundZhang, Q. J., Du, C., Tan, H., Zhang, L., Li, L., Zhang, J., Niu, X., & Liu, J.-R. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.10.016 · Cited by 27
“…PrL, is highly innervated by 5-HT fibers from the midbrain raphe nuclei (Steinbusch, 1981; O’Hearn and Molliver, 1984), and expresses several 5-HT receptor subtypes, such as 5-HT1A, 5-HT2A, 5-HT3 and 5-HT7 (Gustafson et al., 1996; Morales et al., 1996; Neumaier et al., 2001; Santana et al., 2004).”
BackgroundOrsolini, L., Tomasetti, C., Valchera, A., Iasevoli, F., Buonaguro, E. F., Vellante, F., Fornaro, M., Fiengo, A. L. C., Mazza, M., Vecchiotti, R., et al. (2016) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1173545 · Cited by 28
Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats
Noworyta, K., Kamińska, K., Kreiner, G., Rogóż, Z., & Gołembiowska, K. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9654-0 · Cited by 27
“Serotonin 5-HT2A and 5-HT2C receptors are both present on cortical GABA-ergic interneurons (Santana et al. 2004) and their activation has been observed to produce opposing behavioral effects (Fantegrossi et al. 2010).”
BackgroundDevroye, C., Haddjeri, N., Cathala, A., Rovera, R., Drago, F., Piazza, P. V., Artigas, F., & Spampinato, U. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.001 · Cited by 27
“This brain region contains a large population of layer V pyramidal glutamatergic neurons projecting to the VTA, mostly in the prelimbic and infralimbic subdivisions (Gabbott et al., 2005), where 5-HT1ARs are expressed by pyramidal neurons and GABAergic interneurons (Santana et al., 2004).”
Hamati, R., Mansari, M. E., & Blier, P. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0723-y · Cited by 27
Hillert, L., Jovanovic, H., Åhs, F., & Savic, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054781 · Cited by 27
“In a PET study of brain correlates of startle modulation, a function reflecting the interaction between startle and affect, Pissiota and coworkers found, as a result of startle potentiation, a significant increase of rCBF medially in the affective division of ACC, and in a region covering the left amygdala-and hippoca…”
BackgroundPadín, J. F., RODRIGUEZ, M., Domínguez, E., Dopeso‐Reyes, I. G., Buceta, M., CANO, E., Sotelo, E., Brea, J. M., Caruncho, H. J., & ISABELCADAVID, M. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.06.005 · Cited by 27
Pharmacological MRI to investigate the functional selectivity of 5-HT1A receptor biased agonists
Vidal, B., Bolbos, R. I., Redouté, J., Langlois, J., Costes, N., Newman‐Tancredi, A., & Zimmer, L. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107867 · Cited by 26
Comodulation of dopamine and serotonin on prefrontal cortical rhythms: a theoretical study
Wang, D., & Wong‐Lin, K. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00054 · Cited by 26
“…(Pazos and Palacios, 1985; Pompeiano et al., 1992, 1994; Kia et al., 1996; Lopez-Gimenez et al., 1997; Willins et al., 1997; MartinRuiz et al., 2001; Santana et al., 2004; de Almeida and Mengod, 2007; Wedzony et al., 2008; Weber and Andrade, 2010), while a subpopulation of pyramidal cells express…”
BackgroundInfluentialZhang, Q., Wang, S., Liu, J., Ali, U., Gui, Z. H., Wu, Z. H., Hui, Y. P., Wang, Y., & Chen, L. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.052 · Cited by 25
Moreau, A. W., Amar, M., Callebert, J., & Fossier, P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.02.013 · Cited by 25
“…single cell reverse transcription polymerase chain reaction (RTPCR) that the 5-HT1AR is heavily expressed in L5PCs of the primary visual cortex of juvenile rats (Moreau et al., 2010) where it can act as a strong break of axonal output (Cruz et al., 2004; Czyrak et al., 2003; Santana et al., 2004).”
BackgroundGao, J., Nie, L., Li, Y., & Li, M. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107848 · Cited by 25
“, 2015), whereas 5-HT2A receptors are primarily expressed in the pyramidal neurons in layers II/III and V (Amargos-Bosch et al., 2004; Santana et al., 2004).”
BackgroundDopamine and Serotonin Interactively Modulate Prefrontal Cortex Neurons In Vitro
Pietro, N. C. D., & Seamans, J. K. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.007 · Cited by 25
Serotonin–Dopamine Interaction: Experimental Evidence and Therapeutic Relevance
(2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00935-7 · Cited by 25
Distribution of 5-HT receptors in the central nervous system: an update
Vilaró, M. T., Cortés, R., Mengod, G., & Hoyer, D. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00006-2 · Cited by 24
Chen, X., Yue, J., Luo, Y., Huang, L., Li, B., & Wen, S. (2021) · Behavioral and Brain Functions · doi:10.1186/s12993-021-00177-x · Cited by 24
Lladó-Pelfort, L., Troyano‐Rodriguez, E., van den Munkhof, H. E., Cervera‐Ferri, A., Jurado, N., Núñez-Calvet, M., Artigas, F., & Celada, P. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.11.015 · Cited by 24
“Atypical antipsychotic drugs target (directly or indirectly) serotonergic receptors, such as 5-HT1A-R and 5-HT2A-R, which are abundantly expressed in pyramidal and GABAergic neurons (Santana et al., 2004; De Almeida and Mengod, 2008) showing a high degree of cellular co-expression (AmargosBosch et al.”
BackgroundSerotonin Interaction with Other Transmitter Systems
Adell, A., Bortolozzi, A. A., Díaz-Mataix, L., Santana, N., Celada, P., & Artigas, F. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70083-7 · Cited by 23
Self-citationZhang, M., Li, R., Wang, Y., & Huang, Z. (2017) · Neural Plasticity · doi:10.1155/2017/5870735 · Cited by 23
“In the brain, 16 types of 5-HT receptors have been identified [113], and the metabotropic 5-HT1A receptors (5-HT1ARs) are the dominant type in the PFC [114].”
BackgroundHow do stupendous cannabinoids modulate memory processing via affecting neurotransmitter systems?
Vaseghi, S., Nasehi, M., & Zarrindast, M. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.018 · Cited by 23
Gui, Z. H., Zhang, Q. J., Liu, J.-R., Ali, U., Li, L., Wang, Y., Wang, T., Chen, L., Hou, C., & Fan, L. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.059 · Cited by 23
Zhang, Q., Li, L. B., Niu, X. L., Liu, J., Gui, Z. H., Feng, J. J., Ali, U., Hui, Y., & Wu, Z. H. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.086 · Cited by 23
The Role of Serotonin in Aggression and Impulsiveness
Çetin, F. H., Torun, Y. T., & Güney, E. (2017) · InTech eBooks · doi:10.5772/intechopen.68918 · Cited by 23
“In addition, there are nonserotonergic neurons in the projection fields of raphe nucleus in PFC, where 5HT1A and 5HT2A receptors are postsynaptic located [36].”
Gui, Z. H., Zhang, Q. J., Liu, J.-R., Zhang, L., Ali, U., Hou, C., Fan, L., Sun, Y.-N., Wu, Z., & Hui, Y. P. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.05.004 · Cited by 22
5-HT2A Agonists: A Novel Therapy for Functional Neurological Disorders?
Bryson, A., Carter, O. L., Norman, T. R., & Kanaan, R. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx011 · Cited by 22
Depoortère, R., Auclair, A. L., & Newman‐Tancredi, A. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113082 · Cited by 22
Hui, Y. P., Zhang, Q. J., Zhang, L., Chen, L., Guo, Y., Qiao, H. F., Wang, Y., & Liu, J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.033 · Cited by 22
Role of interaction of mGlu2 and 5-HT2A receptors in antipsychotic effects
Ibi, D. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173474 · Cited by 21
Panzini, C. M., Ehlinger, D. G., Alchahin, A. M., Guo, Y., & Commons, K. G. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14227 · Cited by 21
“5-HT2A receptors are expressed in both a subpopulation of pyramidal neurons and approximately one quarter of GABAergic interneurons in cortex (Willins et al. 1997; Santana et al. 2004).”
Background5-HT/GABA interaction in epilepsy
Deidda, G., Crunelli, V., & Giovanni, G. D. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.008 · Cited by 21
Taddeucci, A., Olivero, G., Roggeri, A., Milanese, C., Giorgio, F. P. D., Grilli, M., Marchi, M., Garrone, B., & Pittaluga, A. (2022) · Cells · doi:10.3390/cells11193035 · Cited by 21
Conséquences de l’inter-relation des systèmes monoaminergiques dans l’activité antidépressive
Tritschler, L., Gaillard, R., Gardier, A. M., David, D. J. P., & Guilloux, J. (2018) · L Encéphale · doi:10.1016/j.encep.2018.05.001 · Cited by 21
“[42] Santana N, Bortolozzi A, Serrats J, et al.”
Backgroundd-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortex
Reissig, C. J., Rabin, R. A., Winter, J. C., & Dlugos, C. A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.031 · Cited by 21
Massé, F., NICDHONNCHADHA, B., Hascoët, M., & Bourin, M. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.11.031 · Cited by 21
Kim, S.-H., An, K., Namkung, H., Saito, A., Rannals, M. D., Moore, J. R., Mihaljevic, M., Saha, S., Oh, S., Kondo, M. A., et al. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.21010053 · Cited by 20
Herian, M., Wojtas, A., Sobocińska, M. K., Skawski, M., González-Marín, A., & Gołembiowska, K. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00181-4 · Cited by 20
Polymorphisms of the serotonin receptors genes in patients with bruxism: a systematic review
CAMPELLO, C. P., de Moraes, S. L. D., VASCONCELOS, B. C. D. E., de Lima, E. L. S., PELLIZZER, E. P., Lemos, C. A. A., & Muniz, M. T. C. (2021) · Journal of Applied Oral Science · doi:10.1590/1678-7757-2021-0262 · Cited by 20
Matsuzaki, H., Izumi, T., Matsumoto, M., Togashi, H., Yamaguchi, T., Yoshida, T., Watanabe, M., & Yoshioka, M. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.05.012 · Cited by 20
“Santana et al. (2004) reported that glutamatergic neurons of the medial prefrontal cortex are disinhibited by stimulation of 5-HT1A receptors on GABA interneurons.”
Kolasa, M., Solich, J., Faron‐Górecka, A., Żurawek, D., Pabian, P., Łukasiewicz, S., Kuśmider, M., Szafran‐Pilch, K., Szlachta, M., & Dziedzicka‐Wasylewska, M. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.03.004 · Cited by 20
5-HT2A receptors are involved in cognitive but not antidepressant effects of fluoxetine
Castañé, A., Kargieman, L., Celada, P., Bortolozzi, A. A., & Artigas, F. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.04.006 · Cited by 20
“…in mPFC are 5-HT1A and 5-HT2A receptors, which are expressed by a high percentage of pyramidal neurons and GABAergic interneurons in the rat PFC (Santana et al., 2004) where they mediate excitatory (5-HT2A) and inhibitory (5-HT1A) actions of 5-HT (Araneda and Andrade, 1991; Celada et al., 2013;…”
Castañé, A., Artigas, F., & Bortolozzi, A. A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1205-9 · Cited by 20
“%) of local GABA interneurons (Santana et al. 2004).”
Wang, S., Wang, K., Wang, W.-C., & Sihra, T. S. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21060 · Cited by 20
“…have indicated a somatodendritic localization of 5-HT2A receptors on pyramidal and GABAergic neuron (Willins et al., 1997; Jakab and Goldman-Rakic, 1998; Santana et al., 2004), with a small proportion of receptors on axonal varicosities, which were apparently nonglutamatergic (Miner et al., 2003).”
BackgroundHayashi, T., Ohtani, A., Onuki, F., Natsume, M., Li, F. R., Satou, T., Yoshikawa, M., Senzaki, K., & Shiga, T. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.09.004 · Cited by 20
Alexander, G. M., Graef, J. D., Hammarback, J. A., Nordskog, B. K., Burnett, E. J., Daunais, J. B., Bennett, A. J., Friedman, D. P., Suomi, S. J., & Godwin, D. W. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.01.027 · Cited by 20
“In addition to 5-HT 1A receptors, 5-HT 2A receptors are also densely expressed in cortical neurons (Amargós- Bosch et al., 2004; Santana et al., 2004) and have been shown to play a role in enhancing EPSCs in rat cortical neurons (Aghajanian and Marek, 1997).”
BackgroundG i protein coupling to adenosine A 1 –A 2A receptor heteromers in human brain caudate nucleus
Casadó, V., Barrondo, S., Spasić, M., Callado, L. F., Mallol, J., Canela, E. I., Lluís, C., Meana, J. J., Cortés, A., Sallés, J., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06810.x · Cited by 20
“Thus pyramidal GABAergic neurons in the prefrontal cortex coexpress the Gi-coupled serotonin1A and the Gq-coupled serotonin2A receptors (Santana et al. 2004).”
BackgroundAdaptive mechanisms following antidepressant drugs: Focus on serotonin 5-HT2A receptors
Gawliński, D., Smaga, I., Zaniewska, M., Gawlińska, K., Faron‐Górecka, A., & Filip, M. (2019) · Pharmacological Reports · doi:10.1016/j.pharep.2019.05.012 · Cited by 19
Synthetic surprise as the foundation of the psychedelic experience
Filippo, R. D., & Schmitz, D. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105538 · Cited by 19
“For example, 5-HT 1 R and 5-HT 2 R have opposing effect on the membrane potential, causing respectively inhibition and excitation (Araneda and Andrade, 1991) and can co-localize on the same neuron (Amarg ´ os-Bosch et al., 2004; Santana et al., 2004; Wedzony et al., 2008).”
BackgroundMethodKaneko, F., Kawahara, Y., Kishikawa, Y., Hanada, Y., Yamada, M., Kakuma, T., Kawahara, H., & Nishi, A. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw026 · Cited by 19
“Although 5-HT1A receptors are expressed on both pyramidal neurons and GABAergic interneurons in the PFC (Amargos-Bosch et al., 2004; Santana et al., 2004), 5-HT1A receptor agonists seem to preferentially activate the 5-HT1A receptors on GABAergic interneurons, leading to disinhibition of pyramidal neurons and activati…”
BackgroundKorte, S. M., Prins, J., van den Bergh, F. S., Oosting, R. S., Dupree, R., Korte-Bouws, G. A. H., Westphal, K. G. C., Olivier, B., Denys, D. A. J. P., Garland, A., et al. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.11.024 · Cited by 19
“The behavioral neurobiological mechanisms involved in eltoprazi-ne's actions may be explained as follows: eltoprazine activates both 5-HT 1A - and 5-HT 1B -receptors, probably on GABAergic interneurons in the VTA and 5-HT 1A -receptors on GABAergic interneurons in the peri-LC.”
InfluentialSerotonin signaling in eating disorders
Compan, V., Laurent, L., Jean, A., Macary, C., Bockaert, J., & Dumuis, A. (2012) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.45 · Cited by 19
Effects of Hallucinogens on Neuronal Activity
Lladó-Pelfort, L., Celada, P., Riga, M. S., Troyano‐Rodriguez, E., Santana, N., & Artigas, F. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_473 · Cited by 19
Self-citationMeunier, C. N. J., Callebert, J., Cancela, J., & Fossier, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120286 · Cited by 19
“DA and 5-HT coexist in the PFC [59,60] and 5-HT1ARs are involved in the modulation of dopaminergic activity [42].”
BackgroundYin, L., Yu, Y., Han, F., & Wang, Q. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae258 · Cited by 18
Wright, A., Zapata, A. G., Hoffman, A. F., Necarsulmer, J., Coke, L. M., Svarcbahs, R., Richie, C. T., Pickel, J. M., Hope, B. T., Harvey, B. K., et al. (2021) · eNeuro · doi:10.1523/eneuro.0017-21.2021 · Cited by 18
Hou, C., Li, X., Feng, J., Zhang, L., Wang, Y., Chen, L., Wang, T., Zhang, Q. J., & Liu, J.-R. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.09.012 · Cited by 18
“5-HT1A receptors are also localized postsynaptically to 5-HT terminals, mainly in various regions of the forebrain (Pazos and Palacios, 1985; Pompeiano et al., 1992; Santana et al., 2004).”
BackgroundElectrophysiology of Serotonin Receptors
Marek, G. J. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70077-1 · Cited by 18
Kehr, J., Hu, X.-J., Yoshitake, T., Wang, F.-H., Osborne, P. G., Stenfors, C., & Ögren, S. O. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.03.003 · Cited by 18
“%) of the pyramidal neurons and only about 20% of GABA-ergic interneurons express 5-HT1A receptors (Santana et al., 2004).”
InfluentialPotentiation of excitatory serotonergic responses by MK-801 in the medial prefrontal cortex
Labonté, B., Bambico, F. R., & Gobbi, G. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-009-0446-4 · Cited by 18
“2005) and is highly enriched in various 5-HT receptors, especially the 5-HT1A and the 5-HT2A subtypes, mainly co-expressed on glutamatergic pyramidal neurons (Amargos-Bosch et al. 2004; Santana et al. 2004).”
BackgroundThe serotonin releaser fenfluramine alters the auditory responses of inferior colliculus neurons
Hall, I. C., & Hurley, L. M. (2007) · Hearing Research · doi:10.1016/j.heares.2007.01.023 · Cited by 18
“Alternatively, if neurons express multiple types of serotonin receptors in the IC, a common occurrence in other brain regions (Amargos-Bosch et al., 2004; Beique et al., 2004; Santana et al., 2004), the block of one type of receptor could unmask the effects of another, so that the antagonist could have the same effect…”
Background
Metadata
- Authors
- Santana, N.
- Affiliations
- Consejo Superior de Investigaciones Científicas (ES)
- Corresponding author
- Santana, N.
- ORCID
- Santana, N.
- Venue
- Cerebral Cortex
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-04-27
- Volume
- 14
- Issue
- 10
- Pages
- 1100-1109
- ISSN
- 1047-3211 (ISSN-L)
- 1460-2199
- OpenAlex
- W2156868152
- Cited by
- 486
- References
- 80
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 29 · 2023: 19 · 2022: 11 · 2021: 34 · 2020: 20 · 2019: 14 · 2018: 21 · 2017: 23 · 2016: 23 · 2015: 30 · 2014: 28 · 2013: 28 · 2012: 19
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cerebral Cortex (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- 5-HT1A receptor, 5-HT2A receptor, prefrontal cortex, pyramidal neurons, GABAergic interneurons, glutamatergic neurons, receptor colocalization, atypical antipsychotics, prelimbic cortex, cortical layers
- MeSH terms
- Animals, gamma-Aminobutyric Acid, Gene Expression Regulation, Male, Neurons, Rats, Wistar, Prefrontal Cortex, Pyramidal Cells, Receptor, Serotonin, 5-HT1A, Receptor, Serotonin, 5-HT2A, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.